- Home
- CME
CME
CME Group Inc.
as 05-09-2025 10:33am EST
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
| Founded: | 1898 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 101.1B | IPO Year: | 2002 |
| Target Price: | $255.44 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Hold | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 9.94 | EPS Growth: | 13.21 |
| 52 Week Low/High: | $190.70 - $286.48 | Next Earning Date: | 04-23-2025 |
| Revenue: | $6,274,100,000 | Revenue Growth: | 11.73% |
| Revenue Growth (this year): | 8.12% | Revenue Growth (next year): | 4.32% |
Stock Insider Trading Activity of CME Group Inc. (CME)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Suskind Dennis | CME | Director | Apr 29 '25 | Sell | $271.28 | 1,000 | $271,280.00 | 2,915 | |
| Lucas Deborah J | CME | Director | Mar 14 '25 | Sell | $256.95 | 1,500 | $385,425.00 | 3,356 | |
| SIEGEL HOWARD J | CME | Director | Mar 13 '25 | Sell | $260.00 | 10,000 | $2,600,000.00 | 21,873 | |
| DUFFY TERRENCE A | CME | Chairman and CEO | Mar 11 '25 | Sell | $259.18 | 30,000 | $7,775,400.00 | 53,205 | |
| Sprague Suzanne | CME | COO & Global Head of Clearing | Mar 3 '25 | Sell | $256.83 | 1,500 | $385,249.35 | 8,036 | |
| Piell Hilda Harris | CME | Sr MD & Chief HR Officer | Feb 27 '25 | Sell | $250.47 | 3,984 | $997,852.56 | 27,046 | |
| Vroman Ken | CME | Chief Transformation Officer | Feb 13 '25 | Sell | $250.00 | 5,066 | $1,266,500.00 | 16,715 | |
| Winkler Julie | CME | Sr MD Chief Commercial Officer | Feb 13 '25 | Sell | $249.17 | 11,592 | $2,888,378.64 | 21,885 |
Latest CME Group Inc. News
CME Breaking Stock News: Dive into CME Ticker-Specific Updates for Smart Investing
Simply Wall St.
21 hours ago
CME Group (NasdaqGS:CME) Declares US$1.25 Per Share Dividend for Second Quarter
PR Newswire
a day ago
CME Group Declares Quarterly Dividend
PR Newswire
3 days ago
Farmer sentiment improves as long-term optimism outweighs tariff concerns
Argus Research
3 days ago
Analyst Report: CME Group Inc
Argus Research
3 days ago
Market Digest: CCI, AMP, CMCSA, CME, CVS, ECL, GD, HLF, PFE, PH, UTHR, WDC, PPC
Argus Research
4 days ago
Weekly Stock List
CoinDesk
6 days ago
CME Group Crypto Derivatives Volume Soars 129% in April With ETH Leading the Charge
MT Newswires
7 days ago
CME Group Sets Record April ADV of 35.9 Million Contracts, Up 36% Year Over Year
Compare CME vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CME CME Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.